Gene delivery using helper virus-free HSV-1 amplicon vectors

Current Protocols in Neuroscience

Volumn 1, Issue SUPPL.60, 2012, Pages

  Laimbacher, Andrea S ^a   Fraefel, Cornel ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Amplicon; BAC (bacterial artificial chromosome); Cosmid; Cotransfection; Gene delivery; Helper virus free; Herpes simplex virus; HSV 1 1

Indexed keywords

HERPESVIRUS VECTOR; LIPOSOME; VIRUS DNA;

AMPLICON; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL INTERACTION; CLINICAL PROTOCOL; DNA CLEAVAGE; DNA TRANSFECTION; EXPERIMENTAL DESIGN; GENE VECTOR; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; HOMOLOGOUS RECOMBINATION; NONHUMAN; PRIORITY JOURNAL; PROGENY; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CELL LINE; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HUMAN; METHODOLOGY; ESCHERICHIA COLI;

ANIMALS; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELPER VIRUSES; HERPESVIRUS 1, HUMAN; HUMANS; TRANSFECTION; ESCHERICHIA COLI; VIRUS REPLICATION;

EID: 84868150267     PISSN: 19348584     EISSN: 19348576     Source Type: Journal    
DOI: 10.1002/0471142301.ns0414s60     Document Type: Article

References (22)

1. Aboody-Guterman, K.S., Pechan, P.A., Rainov, N.G., Sena-Esteves, M., Jacobs, A., Snyder, E.Y., Wild, P., Schraner, E., Tobler, K., Breakefield, X.O., and Fraefel, C. 1997. Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vectormediated gene transfer into neural cells in culture and in vivo. Neuroreport 8:3801-3808.
2. Cunningham, C. andDavison, A.J. 1993.Acosmidbased system for constructing mutants of herpes simplex virus type 1. Virology 197:116-124.
3. D'Antuono, A., Laimbacher, A.S., La Torre, J., Tribulatti, V., Romanutti, C., Zamorano, P., Quattrocchi, V., Schraner, E.M., Ackermann, M., Fraefel, C., and Mattion, N. 2010. HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine 28:7363-7372.
4. de Silva, S. and Bowers, W.J. 2009 Herpes virus amplicon vectors. Viruses 1:594-629.
5. Fraefel,C., Song, S., Lim, F., Lang, P.,Yu, L.,Wang, Y.,Wild, P., and Geller, A.I. 1996. Helper virusfree transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70:7190-7197.
6. Fraefel, C., Jacoby, D.R., Lage, C., Hilderbrand, H., Chou, J.Y., Alt, F.W., Breakefield, X.O., and Majzoub, J.A. 1997. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med. 3:813-825.
7. Fraefel, C., Breakefield, X.O., and Jacoby, D.R. 1998. HSV-1 amplicon. In Gene Therapy for Neurological Disorders and Brain Tumors (E.A. Chiocca and X.O. Breakefield, eds.) pp. 63-82.
8. Fraefel, C., Mendes-Madeira, A., Mabon, O., Lefebvre, A., Le Meur, G., Ackermann, M., Moullier, P., and Rolling, F. 2005. In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors. Gene Ther. 12:1283-1288.
9. Geller, A.I. and Breakefield, X.O. 1988. Defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241:1667-1669.
10. Geller, A.I., Keyomarski, K., Bryan, J., and Pardee, A.B. 1990. An efficient deletion mutant packaging system for defective HSV-1 vectors: Potential applications to neuronal physiology and human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 87:8950-8954.
11. Johnston, K.M., Jacoby, D., Pechan, P., Fraefel, C., Borghesani, P., Schuback,D., Dunn, R.J., Smith, F.I., and Breakefield, X.O. 1997. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8:359-370.
12. Kwong, A.D. and Frenkel, N. 1985. The herpes simplex virus amplicon. IV. Efficient expression of chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology 142:421-425.
13. Lim, F., Hartley, D., Starr, P., Lang, P., Song, S., Yu, L.,Wang, Y., and Geller, A.I. 1996. Generation of high-titer defective HSV-1 vectors using an IE2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques 20:458-469.
14. McGeoch, D.J., Dalrymple, M.A., Davison, A.J., Dolan, A., Frame,M.C., McNab, D., Perry, L.J., Scott, J.E., and Taylor, P. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
15. Pechan, P.A., Fotaki, M., Thompson, R.L., Dunn, R.J., Chase,M., Chiocca, E.A., and Breakefield, X.O. 1996. A novel "piggyback" packaging system for herpes simplex virus amplicon vectors. Hum. Gene Ther. 7:2003-2013.
16. Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E.A., Tobler, K., Ackermann, M., Breakefield, X.O., and Fraefel, C. 1998. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replicationcompetent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 9:2787-2794.
17. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X.O., and Chiocca, E.A. 2001. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1DNAin a bacterial artificial chromosome. Mol. Ther. 3:591-601.
18. Sena-Esteves, M., Saeki, Y., Camp, S.M., Chiocca, E.A., and Breakefield, X.O. 1999. Single-step conversion of cells to retrovirus vector producerswith herpes simplex virus-Epstein-Barr virus hybrid amplicons. J. Virol. 73:10426-10439.
19. Smith, I.L., Hardwicke, M.A., and Sandri-Goldin, R.M. 1992. Evidence that the herpes simplex virus immediate-early protein ICP27 acts posttranscriptionally during infection to regulate gene expression. Virology 186:74-86.
20. Spaete, R.R. and Frenkel, N. 1982. The herpes simplex virus amplicon: A new eukaryotic defective-virus cloning-amplifying vector. Cell 30:295-304.
21. Stavropoulos, T.A. and Strathdee, C.A. 1998. An enhanced packaging system for helperdependent herpes simplex virus vectors. J. Virol. 72:7137-7143.
22. Wang, S. and Vos, J. 1996. A hybrid herpes virus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol. 70:8422-8430.